Viewing Study NCT02817451


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-02 @ 1:14 PM
Study NCT ID: NCT02817451
Status: COMPLETED
Last Update Posted: 2022-04-05
First Post: 2016-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module